STOCK TITAN

Azenta, Inc. - $AZTA STOCK NEWS

Welcome to our dedicated page for Azenta news (Ticker: $AZTA), a resource for investors and traders seeking the latest updates and insights on Azenta stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Azenta's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Azenta's position in the market.

Rhea-AI Summary
Azenta, Inc. (AZTA) to participate in 1x1 meetings at Evercore ISI HealthCONx Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
conferences
-
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) reported Q4'23 revenue growth of 25% year over year and 2% on an organic basis. Fiscal year 2023 revenue grew by 20%, with organic growth down 1%. Positive free cash flow was generated for the second consecutive quarter. Fiscal 2024 expects 5-8% organic revenue growth and an additional $500 million in share repurchases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.89%
Tags
-
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) has nominated Didier Hirsch and Martin Madaus for election to the Board of Directors at the 2024 Annual Meeting of Stockholders. The company also reported strong 2023 fourth quarter and full year fiscal 2023 earnings results, with a commitment to an additional $500 million in share repurchases in Fiscal 2024. This follows a significant strategic transformation since 2021, including the sale of its semiconductor automation business in 2022 and the implementation of cost reduction initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.89%
Tags
none
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) announced a Memorandum of Understanding (MOU) between B Medical Systems S.à r.l and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a €100 million National Vaccination Service project. This project includes the delivery of a complete solution for vaccine storage and transport, Toyota vehicles customized with cold chain solutions, and other equipment, with over 50% of the project value expected to be recognized as B Medical revenue for Azenta.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.89%
Tags
none
-
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) to Participate in Stephens Annual Investment Conference in Nashville, Tennessee
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) to announce fiscal Q4 and full year 2023 earnings on November 13, 2023. Conference call and webcast to discuss financial results. Access live webcast at https://investors.azenta.com/events. Replay available on November 14, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.49%
Tags
Rhea-AI Summary
Azenta, Inc. to host GENEWIZ Week featuring virtual workshops and grant program
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.22%
Tags
conferences
-
News
Rhea-AI Summary
Azenta announces new CFO and reaffirms guidance for Q4 fiscal 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
none
-
Rhea-AI Summary
Azenta, Inc. to present at Morgan Stanley Global Healthcare Conference on September 13, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Summary
Azenta, Inc. to present at Baird 2023 Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.89%
Tags
conferences
Azenta, Inc.

Nasdaq:AZTA

AZTA Rankings

AZTA Stock Data

3.09B
49.84M
1.9%
105.44%
7.47%
Semiconductor and Related Device Manufacturing
Manufacturing
Link
United States of America
BURLINGTON

About AZTA

azenta (nasdaq: azta) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. azenta is headquartered in chelmsford, ma, with operations in north america, europe and asia. for more information, please visit www.azenta.com.